novineon Healthcare Technology Partners GmbH

novineon Healthcare Technology Partners GmbH

Private consulting and research company for the healthcare industry

novineon, a consulting company, operates in all sectors of the healthcare industry. With its international network, the company supports manufacturers and users of medical products and services in all aspects of R&D, product assessment and marketing. The company’s three business units, CRO, consulting and holdings/investments, allow the company to focus on the needs of its customers individually, from the analysis of new market opportunities, the development of targeted innovation strategies, to the practical implementation of R&D.

The consulting services of novineon Consulting include, among other things: market studies; technology studies; research on the medical background of new procedures and products; studies on the regulatory framework conditions and the IP situation; new business and innovation strategies; pricing and reimbursement as well as R&D portfolio analysis and platform strategies.

The novineon CRO business unit provides a wide range of services in all areas of preclinical and clinical testing as well as product registration. novineon takes over planning, execution, assessment and documentation of clinical studies and prepares the documents that need to be submitted as part of the approval process. One particular service is the preparation of clinical evaluations.

Research – both contract and in-house research – in the business unit novineon Technologies, is focussed on the development, assessment and validation of new technologies in medicine. The services range from concept development and prototyping, to medical testing of prototypes and validation of new products. The majority of the research activities of the company are carried out in collaboration with national and international partners.

The business unit novineon Ventures actively takes part in the initiating and building of new, innovation-oriented companies and supports them in turning their technologies into marketable commodities. The holdings go back to technologies the company has helped to develop and also to technologies the company has been developing with external partners. The service portfolio extends from the establishment of the business concept and the respective planning documents, to financing the incorporation and start-up phase, up to active support of the management and taking co-management executive positions in the new company.



Activity Biotechnology, Consulting, Service, Studies, Research, Development


Prof. Dr. Marc O. Schurr (Managing Director)

Year of foundation


Supervisory board

Kuno Hönes (Chairman)
Prof. Dr. med. Dietrich H.W. Grönemeyer
Robin Hembry


Joint research project: Tissue engineering with endodermal stem cells and the development of endoscopic technologies for the removal of such cells from the colon


Quality management system certified according to EN ISO 9001/2008 for the business units R&D, consulting and holdings in the field of medical technologies.